Seguir
April Rose, MD, PhD, FRCPC
April Rose, MD, PhD, FRCPC
Clinician Scientist, McGill University
Dirección de correo verificada de mail.mcgill.ca
Título
Citado por
Citado por
Año
Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations
M Dankner, AAN Rose, S Rajkumar, PM Siegel, IR Watson
Oncogene 37 (24), 3183-3199, 2018
4062018
ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties
AAN Rose, MG Annis, Z Dong, F Pepin, M Hallett, M Park, PM Siegel
PloS one 5 (8), e12093, 2010
2222010
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer
AAN Rose, AA Grosset, Z Dong, C Russo, PA MacDonald, NR Bertos, ...
Clinical cancer research 16 (7), 2147-2156, 2010
2182010
Osteoactivin promotes breast cancer metastasis to bone
AAN Rose, F Pepin, C Russo, JE Abou Khalil, M Hallett, PM Siegel
Molecular Cancer Research 5 (10), 1001-1014, 2007
2182007
GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis
AB Dydensborg, AAN Rose, BJ Wilson, D Grote, M Paquet, V Giguere, ...
Oncogene 28 (29), 2634-2642, 2009
1732009
Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer
G Maric, AAN Rose, MG Annis, PM Siegel
OncoTargets and therapy, 839-852, 2013
1522013
Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer
J Bendell, M Saleh, AAN Rose, PM Siegel, L Hart, S Sirpal, S Jones, ...
Journal of Clinical Oncology 32 (32), 3619-3625, 2014
1192014
Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases
S Tabariès, V Ouellet, BE Hsu, MG Annis, AAN Rose, L Meunier, ...
Breast cancer research 17, 1-18, 2015
1172015
Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis
AAN Rose, C Elser, M Ennis, PJ Goodwin
Breast cancer research and treatment 141, 331-339, 2013
1132013
Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells
M Demers, AAN Rose, AA Grosset, K Biron-Pain, L Gaboury, PM Siegel, ...
The American journal of pathology 176 (6), 3023-3031, 2010
1002010
Emerging therapeutic targets in breast cancer bone metastasis
AAN Rose, PM Siegel
Future oncology 6 (1), 55-74, 2010
922010
Targeting GPNMB with glembatumumab vedotin: current developments and future opportunities for the treatment of cancer
AAN Rose, M Biondini, R Curiel, PM Siegel
Pharmacology & therapeutics 179, 127-141, 2017
852017
GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis
G Maric, MG Annis, Z Dong, AAN Rose, S Ng, D Perkins, PA MacDonald, ...
Oncogene 34 (43), 5494-5504, 2015
762015
Breast cancer-derived factors facilitate osteolytic bone metastasis
AA Rose, PM Siegel
Bull Cancer 93 (9), 931-943, 2006
732006
Dual MAPK inhibition is an effective therapeutic strategy for a subset of class II BRAF mutant melanomas
M Dankner, M Lajoie, D Moldoveanu, TT Nguyen, P Savage, S Rajkumar, ...
Clinical Cancer Research 24 (24), 6483-6494, 2018
672018
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
A Rogiers, IP Da Silva, C Tentori, CA Tondini, JM Grimes, MH Trager, ...
Journal for ImmunoTherapy of Cancer 9 (1), 2021
602021
MAPK pathway inhibitors sensitize BRAF-mutant melanoma to an antibody-drug conjugate targeting GPNMB
AAN Rose, MG Annis, DT Frederick, M Biondini, Z Dong, L Kwong, L Chin, ...
Clinical Cancer Research 22 (24), 6088-6098, 2016
512016
Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+ anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy
AAN Rose, SM Armstrong, D Hogg, MO Butler, SD Saibil, DP Arteaga, ...
Journal for immunotherapy of cancer 9 (1), 2021
382021
Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities
A Bemmo, C Dias, AAN Rose, C Russo, P Siegel, J Majewski
PloS one 5 (8), e11981, 2010
372010
Osteoactivin/HGFIN: is it a tumor suppressor or mediator of metastasis in breast cancer?
AAN Rose, PM Siegel
Breast Cancer Research 9, 1-2, 2007
312007
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20